Table 5 Longitudinal Outcomes in YMRS and HAM-D: monotherapy versus individual combination therapies
Predictors | YMRS | HAM-D | ||||
|---|---|---|---|---|---|---|
Estimates | CI | p | Estimates | CI | p | |
Group [Li] | 1.80 | − 1.77–5.37 | 0.319 | 2.29 | − 0.87–5.45 | 0.153 |
Group [QTP] | − 0.83 | − 4.36–2.69 | 0.640 | 0.66 | − 2.46–3.78 | 0.675 |
Time [days] | − 0.13 | − 0.18 to − 0.08 | < 0.001*** | − 0.05 | − 0.09 to − 0.02 | 0.004** |
Site [VA] | 0.41 | − 3.31–4.13 | 0.826 | − 4.60 | − 8.14 to − 1.07 | 0.011* |
Group [Li] × time | − 0.06 | − 0.14–0.01 | 0.108 | − 0.00 | − 0.06–0.05 | 0.878 |
Group [QTP] × time | 0.00 | − 0.06–0.07 | 0.919 | 0.04 | − 0.01–0.09 | 0.124 |